CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$49.39 -0.60 (-1.20%)
At close: Oct 23, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

CRISPR Therapeutics AG (CRSP) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 CRISPR Therapeutics AG 4.77 Bn -3.92 Bn - 162.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162.49 Mn
Mar 31, 2026 340.47 Mn
Dec 31, 2025 300.69 Mn
Sep 30, 2025 214.93 Mn
Jun 30, 2025 310.18 Mn
Mar 31, 2025 186.18 Mn
Dec 31, 2024 373.00 Mn
Sep 30, 2024 247.68 Mn
Jun 30, 2024 349.78 Mn
Mar 31, 2024 237.34 Mn
Dec 31, 2023 287.43 Mn
Sep 30, 2023 369.87 Mn
Jun 30, 2023 408.71 Mn
Mar 31, 2023 386.52 Mn
Dec 31, 2022 325.06 Mn
Sep 30, 2022 419.75 Mn
Jun 30, 2022 227.55 Mn
Mar 31, 2022 223.98 Mn
Dec 31, 2021 123.01 Mn
Sep 30, 2021 142.67 Mn
API Access

CRISPR Therapeutics AG Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CRSP&period=max&api_key=YOUR_API_KEY